• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C5aR 在转移性肾细胞癌中常被表达,并通过 ERK 和 PI3 激酶途径在细胞侵袭中发挥关键作用。

C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.

机构信息

Department of Urology, Faculty of Life Sciences, Kumamoto University, Kumamoto 860‑8556, Japan.

Medical Quality Management Center, Kumamoto University Hospital, Kumamoto 860-0811, Japan.

出版信息

Oncol Rep. 2015 Apr;33(4):1844-50. doi: 10.3892/or.2015.3800. Epub 2015 Feb 13.

DOI:10.3892/or.2015.3800
PMID:25682807
Abstract

The anaphylatoxin C5a is a chemoattractant for leukocyte migration via the C5a receptor (C5aR). We recently reported that C5aR was aberrantly expressed in a wide variety of human related cancers, while it also promotes cancer cell invasion by C5a stimulation. However, the biological significance of C5aR expression in renal cell carcinoma (RCC) has not yet been clarified. In the present study, we aimed to elucidate the biological role of C5aR in RCC progression. Clinical RCC specimens were analyzed for C5aR expression and its relationship with baseline demographic data and clinicopathological parameters was analyzed. Moreover, renal carcinoma Renca cells stably expressing C5aR were generated and used to assess the effects of C5a-C5aR axis activation on various cellular phenomena in culture. Immunohistochemistry revealed that 96.7% of the metastatic RCCs (mRCCs) showed C5aR expression, whereas only 50.5% of the non-metastatic RCCs expressed C5aR (P<0.001). Although C5a stimulation did not significantly alter anoikis of C5aR‑expressing Renca cells, C5a elicited cell morphological change and scattering of those cells accompanied with dynamic actin rearrangement, which was not observed in the Renca cells harboring the empty vector only. Moreover, C5a triggered ERK and PI3K‑dependent invasion of the C5aR-expressing renal carcinoma cells. These results are consistent with the idea that the C5a-C5aR axis plays a crucial role in renal carcinoma cell invasion, which may be one of the key steps for RCC metastasis. The present study provides proof‑of‑concept that the C5a-C5aR axis may be a useful therapeutic target for preventing RCC progression.

摘要

过敏毒素 C5a 通过 C5a 受体 (C5aR) 作为白细胞迁移的趋化因子。我们最近报道 C5aR 在多种人类相关癌症中异常表达,而 C5a 刺激也通过促进癌细胞侵袭来促进癌症进展。然而,C5aR 在肾细胞癌 (RCC) 中的表达的生物学意义尚未阐明。在本研究中,我们旨在阐明 C5aR 在 RCC 进展中的生物学作用。分析了临床 RCC 标本中 C5aR 的表达情况,并分析了其与基线人口统计学数据和临床病理参数的关系。此外,还生成了稳定表达 C5aR 的肾癌细胞系 Renca 细胞,并用于评估 C5a-C5aR 轴激活对培养中各种细胞现象的影响。免疫组织化学显示,96.7%的转移性 RCC (mRCC) 显示 C5aR 表达,而只有 50.5%的非转移性 RCC 表达 C5aR (P<0.001)。虽然 C5a 刺激并没有显著改变表达 C5aR 的 Renca 细胞的凋亡,但 C5a 引起了细胞形态的变化和这些细胞的散射,伴随着动态肌动蛋白重排,而仅携带空载体的 Renca 细胞则没有观察到这种情况。此外,C5a 触发了表达 C5aR 的肾癌细胞的 ERK 和 PI3K 依赖性侵袭。这些结果与 C5a-C5aR 轴在肾癌细胞侵袭中发挥关键作用的观点一致,这可能是 RCC 转移的关键步骤之一。本研究提供了概念验证,即 C5a-C5aR 轴可能是预防 RCC 进展的一个有前途的治疗靶点。

相似文献

1
C5aR is frequently expressed in metastatic renal cell carcinoma and plays a crucial role in cell invasion via the ERK and PI3 kinase pathways.C5aR 在转移性肾细胞癌中常被表达,并通过 ERK 和 PI3 激酶途径在细胞侵袭中发挥关键作用。
Oncol Rep. 2015 Apr;33(4):1844-50. doi: 10.3892/or.2015.3800. Epub 2015 Feb 13.
2
Enhancement of human cancer cell motility and invasiveness by anaphylatoxin C5a via aberrantly expressed C5a receptor (CD88).过敏毒素 C5a 通过异常表达的 C5a 受体(CD88)增强人癌细胞的迁移和侵袭能力。
Clin Cancer Res. 2013 Apr 15;19(8):2004-13. doi: 10.1158/1078-0432.CCR-12-1204. Epub 2013 Jan 3.
3
C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition.C5a受体通过激活ERK1/2介导的上皮-间质转化增强肝癌细胞的侵袭性。
Exp Mol Pathol. 2016 Feb;100(1):101-8. doi: 10.1016/j.yexmp.2015.10.001. Epub 2015 Oct 22.
4
C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA.C5a受体(CD88)通过激活RhoA促进胃癌的运动性和侵袭性。
Oncotarget. 2016 Dec 20;7(51):84798-84809. doi: 10.18632/oncotarget.12656.
5
Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a.前列腺癌 C5a 受体表达及 C5a 增强癌细胞增殖、侵袭和 PD-L1 表达。
Prostate. 2021 Feb;81(3):147-156. doi: 10.1002/pros.24090. Epub 2020 Dec 24.
6
Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma.C5a-C5aR轴的富集预示着透明细胞肾细胞癌患者术后预后不良。
Oncotarget. 2016 Dec 6;7(49):80925-80934. doi: 10.18632/oncotarget.13108.
7
Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.补体 C5a/C5aR 途径通过下调 p21 表达促进胃癌的发病机制。
Cancer Lett. 2018 Jan 1;412:30-36. doi: 10.1016/j.canlet.2017.10.003. Epub 2017 Oct 12.
8
Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis.C5a-C5a受体系统对乳腺癌进展及患者预后的影响。
Breast Cancer. 2016 Nov;23(6):876-885. doi: 10.1007/s12282-015-0654-3. Epub 2015 Oct 22.
9
Functional identification of the stable transfection C5aR cell line Molt-4.稳定转染C5aR细胞系Molt-4的功能鉴定。
Cell Mol Immunol. 2007 Dec;4(6):461-5.
10
The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells.核糖体蛋白 S19 C 端在 C5a 受体介导的 Gi 蛋白依赖性人肥大细胞 HMC-1 细胞中 p38MAP 激酶的替代激活中的作用。
Apoptosis. 2010 Aug;15(8):966-81. doi: 10.1007/s10495-010-0511-y.

引用本文的文献

1
Non-canonical extracellular complement pathways and the complosome paradigm in cancer: a scoping review.癌症中的非经典细胞外补体途径与补体体范式:一项范围综述
Front Immunol. 2025 Apr 30;16:1519465. doi: 10.3389/fimmu.2025.1519465. eCollection 2025.
2
The complement system and kidney cancer: pathogenesis to clinical applications.补体系统与肾癌:从发病机制到临床应用
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188351.
3
C5aR1 Promotes Invasion, Metastasis, and Poor Prognosis in Cutaneous Squamous Cell Carcinoma.C5aR1促进皮肤鳞状细胞癌的侵袭、转移及预后不良。
Am J Pathol. 2025 Jun;195(6):1158-1171. doi: 10.1016/j.ajpath.2025.02.004. Epub 2025 Mar 6.
4
Single-Cell RNA Sequencing Reveals That C5AR1 in Follicle Monocyte Cells Could Predict the Development of POI.单细胞RNA测序揭示卵泡单核细胞中的C5AR1可预测卵巢早衰的发展。
J Inflamm Res. 2024 Dec 18;17:11221-11234. doi: 10.2147/JIR.S490996. eCollection 2024.
5
Complement or insult: the emerging link between complement cascade deficiencies and pathology of myeloid malignancies.补体系统缺陷与髓系恶性肿瘤发病机制之间新的关联:补充还是损伤?
J Leukoc Biol. 2024 Nov 4;116(5):966-984. doi: 10.1093/jleuko/qiae130.
6
Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a.外泌体生物标志物在卵巢肿瘤鉴别诊断中的作用:CA125、HE4 和 C5a 的新作用。
J Ovarian Res. 2024 Jan 5;17(1):4. doi: 10.1186/s13048-023-01336-6.
7
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
8
C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer.C5aR1 阻断重塑免疫抑制性肿瘤微环境,并与免疫检查点阻断疗法在高级别浆液性卵巢癌中协同作用。
Oncoimmunology. 2023 Sep 30;12(1):2261242. doi: 10.1080/2162402X.2023.2261242. eCollection 2023.
9
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer.靶向补体C5a以提高非小细胞肺癌的放疗敏感性。
Transl Lung Cancer Res. 2023 May 31;12(5):1093-1107. doi: 10.21037/tlcr-23-258. Epub 2023 May 29.
10
The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review.C5a-C5aR1轴在骨病理生理学中的作用:一篇综述
Front Cell Dev Biol. 2022 Aug 8;10:957800. doi: 10.3389/fcell.2022.957800. eCollection 2022.